Skip to content

Blog

Author: Scientific Office

<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

Answers to Your Questions on Immunogenicity Testing for Biosimilars: Part 2

  • February 26, 2020

BioAgilytix’s Todd Lester answers additional questions submitted by attendees of his recent Bioanalysis Zone webinar on immunogenicity testing for biosimilars.

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

Questions on Immunogenicity Testing for Biosimilars Answered: Part 1

  • February 18, 2020

BioAgilytix’s Todd Lester answers questions submitted by attendees of his recent Bioanalysis Zone webinar on immunogenicity testing for biosimilars.

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

Bioanalytical Testing Under GMP: Assuring Biologic Safety & Efficacy via Impurities Assays

  • February 6, 2020

We discuss the need to put phase-appropriate methods in place to identify and quantify both process- and host-cell related impurities throughout the drug development process.

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

Bioanalytical Strategies to Support Biosimilar Programs: How BioAgilytix is Helping to Shape Best Practices

  • January 2, 2020

BioAgilytix has been fortunate enough to have several of our team members participate as co-authors on all three AAPS white papers in the series on…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

A Dose of Pharma and Biotech News: December 12, 2019

  • December 12, 2019

With innovative research driving pharmaceutical and biotech breakthroughs, industry progress is accelerating at a rapid pace. We've compiled some recent industry articles on the latest…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/uncategorized/">Uncategorized</a>

Bioanalytical Testing Under GMP: Optimizing Cell-Based Potency Assays

  • December 4, 2019

Cell-based bioassays are expected by health agencies as one of the release specification methods for potency assessments in the drug development process. We take a…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Tatjana Ackermann, Quality Assurance Auditor

  • November 6, 2019

We strive to foster an environment where our team members can continually grow within their role and within the company – not only upwards, but…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

CRISPR-Cas9 Milestones: The First In Vivo Clinical Trial Is Now Underway in Boston

  • October 29, 2019

The first in-human in vivo clinical trial using CRISPR-Cas9 is now open for enrollment; we take a closer look at this genome editing technology to…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

BioAgilytix Team Q&A: Meet Janett Schwarz, Principal Investigator at BioAgilytix

  • October 10, 2019

In our latest Team Q&A, we talk to Janett Schwarz, Principal Investigator at BioAgilytix’s European headquarters, about how her role has evolved since joining our…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/industry-update/">Industry Update</a>

Event Line-Up: The Bioanalytical Industry Forums We’ll Be at This Fall

  • October 3, 2019

We're looking forward to participating in several upcoming bioanalytical conferences and events this fall, ranging from small-circle workshops to global, world-renowned industry forums.

Find Out More